Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway

PLoS Pathogens

Volumn 5, Issue 10, 2009, Pages

  Kemball, Christopher C ^a   Harkins, Stephanie ^a   Whitmire, Jason K ^a   Flynn, Claudia T ^a   Feuer, Ralph ^b   Whitton, J Lindsay ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; HLA ANTIGEN CLASS 1; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; CROSS PRESENTATION; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; SENSOR; VIRUS INHIBITION; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECT; ENTEROVIRUS; GENETICS; HELA CELL; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; VIROLOGY;

COXSACKIEVIRUS;

ANIMALS; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; EPITOPES; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC MEMORY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION;

EID: 73449110595     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000618     Document Type: Article

References (65)

1. Modlin JF, Rotbart HA (1997) Group B coxsackie disease in children. Curr Top Microbiol Immunol 223: 53-80.
2. Whitton JL (2002) Immunopathology during coxsackievirus infection. Springer Semin Immunopathol 24: 201-213.
3. Romero JR (2008) Pediatric group B coxsackievirus infections. Curr Top Microbiol Immunol 323: 223-239.
4. O'Connell JB (1987) The role of myocarditis in end-stage dilated cardiomyopathy. Tex Heart Inst J 14: 268-275.
5. Sole MJ, Liu P (1993) Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. J Am Coll Cardiol 22: 99A-105A.
6. Tam PE (2006) Coxsackievirus Myocarditis: Interplay between Virus and Host in the Pathogenesis of Heart Disease. Viral Immunol 19: 133-146.
7. Daley AJ, Isaacs D, Dwyer DE, Gilbert GL (1998) A cluster of cases of neonatal coxsackievirus B meningitis and myocarditis. J Paediatr Child Health 34: 196-198.
8. Mena I, Fischer C, Gebhard JR, Perry CM, Harkins S, et al. (2000) Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. Virology 271: 276-288.
9. Huber S, Ramsingh AI (2004) Coxsackievirus-induced pancreatitis. Viral Immunol 17: 358-369.
10. Feuer R, Pagarigan RR, Harkins S, Liu F, Hunziker IP, et al. (2005) Coxsackievirus targets proliferating neuronal progenitor cells in the neonatal CNS. J Neurosci 25: 2434-2444.
11. +T cells during picornavirus infection. J Virol 75: 2377-2387.
12. + T cells in lymphoid and peripheral sites of coxsackievirus B3 infection. J Virol 82: 4331-4342.
13. Crocker SJ, Frausto RF, Whitmire JK, Benning N, Whitton JL (2007) Amelioration of coxsackievirus B3-mediated myocarditis by inhibition of TIMP-1. Am J Pathol 171: 1762-1773.
14. +dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis. J Virol 82: 8149-8160.
15. + T cell priming against Mycobacterium bovis (bacillus Calmette-Guerin). J Immunol 179: 211-220.
16. + T cell lineage commitment. Nat Immunol 6: 793-799.
17. + T cell survival controlled by clonal abundance. Science 312: 114-116.
18. Foulds KE, Shen H (2006) Clonal competition inhibits the proliferation and differentiation of adoptively transferred TCR transgenic CD4 T cells in response to infection. J Immunol 176: 3037-3043.
19. + T Cell Response to Infection. Immunity 26: 827-841.
20. Sarkar S, Teichgraber V, Kalia V, Polley A, Masopust D, et al. (2007) Strength of stimulus and clonal competition impact the rate of memory CD8 T cell differentiation. J Immunol 179: 6704-6714.
21. + T cell precursor frequency leads to competition for IFNγ, thereby degrading memory cell quantity and quality. J Immunol 180: 6777-6785.
22. + T cell memory. J Immunol 179: 1190-1197.
23. + T cell repertoire in the transition from effector to memory. Immunity 28: 533-545.
24. Blattman JN, Antia R, Sourdive DJ, Wang X, Kaech SM, et al. (2002) Estimating the precursor frequency of naive antigen-specific CD8 T cells. J Exp Med 195: 657-664.
25. + T cells. J Immunol 176: 3028-3036.
26. + T cells can be distinguished by their cytokine profiles and phenotypic markers. J Immunol 164: 208-216.
27. Masopust D, Ha SJ, Vezys V, Ahmed R (2006) Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. J Immunol 177: 831-839.
28. Huber S (2008) Host immune responses to coxsackievirus B3. Curr Top Microbiol Immunol 323: 199-221.
29. Huber SA, Job LP, Woodruff JF (1980) Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes. Am J Pathol 98: 681-694.
30. Huber SA, Job LP (1983) Cellular immune mechanisms in Coxsackievirus group B, type 3 induced myocarditis in Balb/C mice. Adv Exp Med Biol 161: 491-508.
31. Guthrie M, Lodge PA, Huber SA (1984) Cardiac injury in myocarditis induced by Coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2+ cytolytic lymphocytes. Cell Immunol 88: 558-567.
32. Huber S, Polgar J, Moraska A, Cunningham MW, Schwimmbeck P, et al. (1993) T lymphocyte responses in CVB3-induced murine myocarditis. Scand J Infect Dis Suppl 88: 67-78.
33. + T-cell epitopes shared among group B enteroviruses. J Gen Virol 89: 2090-2097.
34. Wessels E, Duijsings D, Notebaart RA, Melchers WJ, van Kuppeveld FJ (2005) A proline-rich region in the coxsackievirus 3A protein is required for the protein to inhibit endoplasmic reticulum-to-golgi transport. J Virol 79: 5163-5173.
35. Wessels E, Notebaart RA, Duijsings D, Lanke K, Vergeer B, et al. (2006) Structure-function analysis of the coxsackievirus protein 3A: identification of residues important for dimerization, viral RNA replication, and transport inhibition. J Biol Chem 281: 28232-28243.
36. de Jong AS, Visch HJ, de Mattia F, van Dommelen MM, Swarts HG, et al. (2006) The coxsackievirus 2B protein increases efflux of ions from the endoplasmic reticulum and Golgi, thereby inhibiting protein trafficking through the Golgi. J Biol Chem 281: 14144-14150.
37. Cornell CT, Kiosses WB, Harkins S, Whitton JL (2006) Inhibition of protein trafficking by coxsackievirus B3: multiple viral proteins target a single organelle. J Virol 80: 6637-6647.
38. Cornell CT, Kiosses WB, Harkins S, Whitton JL (2007) Coxsackievirus B3 proteins directionally complement each other to downregulate surface MHC class I. J Virol 81: 6785-6797.
39. Dodd DA, Giddings TH, Jr., Kirkegaard K (2001) Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection. J Virol 75: 8158-8165.
40. Neznanov N, Kondratova A, Chumakov KM, Angres B, Zhumabayeva B, et al. (2001) Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from the cell surface. J Virol 75: 10409-10420.
41. Kramer M, Schulte BM, Toonen LW, de Bruijni MA, Galama JM, et al. (2007) Echovirus infection causes rapid loss-of-function and cell death in human dendritic cells. Cell Microbiol 9: 1507-1518.
42. Huhn MH, Hultcrantz M, Lind K, Ljunggren HG, Malmberg KJ, et al. (2008) IFN-γ production dominates the early human natural killer cell response to Coxsackievirus infection. Cell Microbiol 10: 426-436.
43. Huber SA, Feldman AM, Sartini D (2006) Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-a transgenic mice. Circ Res 99: 1109-1116.
44. +T cells without selection of higher affinity TCR. Nat Immunol 2: 711-717.
45. Wessels E, Duijsings D, Niu TK, Neumann S, Oorschot VM, et al. (2006) A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1. Dev Cell 11: 191-201.
46. + T cell cross-priming via transfer of proteasome substrates. Science 304: 1318-1321.
47. + dendritic cells. Nat Immunol 10: 488-495.
48. + T cells by viral and tumor antigens is a robust phenomenon. Eur J Immunol 34: 194-199.
49. Heath WR, Belz GT, Behrens GM, Smith CM, Forehan SP, et al. (2004) Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 199: 9-26.
50. + T-cell immunity and tolerance. Cell Death Differ 16: 79-86.
51. Paludan C, Schmid D, Landthaler M, Vockerodt M, Kube D, et al. (2005) Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307: 593-596.
52. Strawbridge AB, Blum JS (2007) Autophagy in MHC class II antigen processing. Curr Opin Immunol 19: 87-92.
53. Munz C (2009) Enhancing Immunity Through Autophagy. Annu Rev Immunol 27: 423-449.
54. +FoxP3 (T regulatory) cell response in coxsackievirus B3-induced myocarditis. Immunology 127: 567-576.
55. Halim SS, Collins DN, Ramsingh AI (2000) A therapeutic HIV vaccine using coxsackie-HIV recombinants: A possible new strategy. AIDS Res Hum Retroviruses 16: 1551-1558.
56. Halim SS, Ostrowski SE, Lee WT, Ramsingh AI (2001) Immunogenicity of a foreign peptide expressed within a capsid protein of an attenuated coxsackie-virus. Vaccine 19: 958-965.
57. Blair DA, Lefrancois L (2007) Increased competition for antigen during priming negatively impacts the generation of memory CD4 T cells. Proc Natl Acad Sci U S A 104: 15045-15050.
58. + T cell recall responses is controlled by the duration of the secondary stimulus. J Immunol 183: 2382-2389.
59. Pircher H, Moskophidis D, Rohrer U, Burki K, Hengartner H, et al. (1990) Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346: 629-633.
60. Oxenius A, Bachmann MF, Zinkernagel RM, Hengartner H (1998) Virusspecific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur J Immunol 28: 390-400.
61. Whitmire JK, Eam B, Whitton JL (2008) Tentative T cells : memory cells are quick to respond, but slow to divide. PLoS Pathog 4: e1000041. doi:10.1371/ journal.ppat.1000041.
62. van Houten N, Bouchard PE, Moraska A, Huber SA (1991) Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen. J Virol 65: 1286-1290.
63. Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber SA (1996) A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol 70: 7811-7818.
64. Hunziker IP, Cornell CT, Whitton JL (2007) Deletions within the 5′UTR of coxsackievirus B3: consequences for virus translation and replication. Virology 360: 120-128.
65. + T cells following PMA stimulation. J Interferon Cytokine Res 21: 503-506.